Israel Englander Athira Pharma, Inc. Transaction History

Millennium Management LLC

$224 Billion
Q1 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Athira Pharma, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 141,661 shares of ATHA stock, worth $371,151. This represents 0.0% of its overall portfolio holdings.

Number of Shares

141,661

Previous 455,857 68.92%

Holding current value

$371,151

Previous $1.11 Million 64.95%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$2.24 - $4.15 $703,799 - $1.3 Million	-314,196 Reduced 68.92%	141,661 $388,000
Q4 2023 Feb 14, 2024	SELL	$1.39 - $2.46 $484,508 - $857,474	-348,567 Reduced 43.33%	455,857 $1.11 Million
Q2 2023 Aug 14, 2023	BUY	$2.36 - $3.59 $643,059 - $978,213	272,483 Added 51.22%	804,424 $2.37 Million
Q1 2023 May 15, 2023	BUY	$2.26 - $4.22 $1.12 Million - $2.09 Million	495,515 Added 1360.33%	531,941 $1.33 Million
Q4 2022 Feb 14, 2023	BUY	$2.76 - $3.37 $21,842 - $26,670	7,914 Added 27.76%	36,426 $115,000

Q3 2022 Nov 14, 2022	SELL	$3.12 - $3.96 $18,083 - $22,952	-5,796 Reduced 16.89%	28,512 $85,000
Q2 2022 Aug 15, 2022	BUY	$2.74 - $13.43 $94,003 - $460,756	34,308 New	34,308 $105,000
Q3 2021 Nov 15, 2021	SELL	$9.15 - $11.09 $474,363 - $574,938	-51,843 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$10.24 - $20.87 $4.7 Million - $9.57 Million	-458,552 Reduced 89.84%	51,843 $531,000
Q1 2021 May 17, 2021	BUY	$16.9 - $29.77 $6.89 Million - $12.1 Million	407,549 Added 396.27%	510,395 $9.39 Million
Q4 2020 Feb 16, 2021	SELL	$16.48 - $34.3 $2.02 Million - $4.21 Million	-122,646 Reduced 54.39%	102,846 $3.52 Million
Q3 2020 Nov 16, 2020	BUY	$16.02 - $18.46 $3.61 Million - $4.16 Million	225,492 New	225,492 $4.16 Million

Others Institutions Holding ATHA

# of Institutions

Shares Held

22.3M

Call Options Held

77.1K

Put Options Held

42.4K

View Full List

About Athira Pharma, Inc.

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $99.1M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

More about ATHA

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account